PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+27%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$577M
AUM Growth
+$577M
(+25%)
Cap. Flow
+$87.3M
Cap. Flow
% of AUM
15.13%
Top 10 Holdings %
Top 10 Hldgs %
35.5%
Holding
108
New
25
Increased
54
Reduced
16
Closed
13
Top Buys
| 1 |
Cencora
COR
|
$16.6M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$15.9M |
| 3 |
Becton Dickinson
BDX
|
$11.6M |
| 4 |
Danaher
DHR
|
$10.9M |
| 5 |
Insulet
PODD
|
$8.45M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$10.5M |
| 2 |
Elevance Health
ELV
|
$9.95M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.72M |
| 4 |
Eli Lilly
LLY
|
$9.5M |
| 5 |
IQVIA
IQV
|
$9.08M |
Sector Composition
| 1 | Healthcare | 98.94% |
| 2 | Industrials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$13.8B
| $27.1M | 4.71% | 122,978 +14,906 | +14% | +$3.29M |
|
2
Boston Scientific
BSX
$156B
| $25.6M | 4.44% | 473,105 +44,874 | +10% | +$2.43M |
|
3
Schrodinger
SDGR
$1.44B
| $24.1M | 4.18% | 482,626 +83,456 | +21% | +$4.17M |
|
|
4
Becton Dickinson
BDX
$55.3B
| $22.1M | 3.83% | 83,646 +43,858 | +110% | +$11.6M |
|
5
Tenet Healthcare
THC
$16.3B
| $20.7M | 3.58% | 254,037 +68,205 | +37% | +$5.55M |
|
6
Lantheus
LNTH
$3.73B
| $20.6M | 3.57% | 245,547 +58,360 | +31% | +$4.9M |
|
|
7
Insulet
PODD
$23.9B
| $16.7M | 2.9% | 58,051 +29,307 | +102% | +$8.45M |
|
|
8
Cencora
COR
$56.5B
| $16.6M | 2.88% | +86,250 | New | +$16.6M |
|
|
IMGN
9
DELISTED
Immunogen Inc
IMGN
| $15.9M | 2.75% | +840,811 | New | +$15.9M |
|
10
Cooper Companies
COO
$13.4B
| $15.4M | 2.67% | 40,123 -12,261 | -23% | -$4.7M |
|
|
11
Danaher
DHR
$147B
| $14.6M | 2.53% | 60,696 +45,480 | +299% | +$10.9M |
|
12
RxSight
RXST
$370M
| $14.4M | 2.49% | 498,631 +70,838 | +17% | +$2.04M |
|
13
Neurocrine Biosciences
NBIX
$13.8B
| $13.2M | 2.28% | 139,735 -78,103 | -36% | -$7.37M |
|
14
Vaxcyte
PCVX
$4B
| $11.4M | 1.98% | 228,505 +42,408 | +23% | +$2.12M |
|
15
Keros Therapeutics
KROS
$618M
| $11.1M | 1.93% | 276,815 +97,525 | +54% | +$3.92M |
|
16
DexCom
DXCM
$29.5B
| $10.9M | 1.9% | 85,126 +6,199 | +8% | +$797K |
|
17
Waters Corp
WAT
$18B
| $10.8M | 1.88% | 40,688 +28,821 | +243% | +$7.68M |
|
|
KRTX
18
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $10.7M | 1.85% | 49,233 +9,926 | +25% | +$2.15M |
|
|
SILK
19
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $9.99M | 1.73% | 307,525 +67,661 | +28% | +$2.2M |
|
20
Haemonetics
HAE
$2.63B
| $9.8M | 1.7% | 115,061 -25,679 | -18% | -$2.19M |
|
21
ANI Pharmaceuticals
ANIP
$2.03B
| $9.39M | 1.63% | 174,477 +74,477 | +74% | +$4.01M |
|
|
VRNA
22
Verona Pharma
VRNA
$9.16B
| $8.48M | 1.47% | 400,987 -87,008 | -18% | -$1.84M |
|
23
Xenon Pharmaceuticals
XENE
$2.98B
| $8.38M | 1.45% | 217,740 -59,543 | -21% | -$2.29M |
|
|
DCPH
24
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $8.07M | 1.4% | 573,239 +81,467 | +17% | +$1.15M |
|
25
MannKind Corp
MNKD
$1.41B
| $7.39M | 1.28% | 1,816,581 +342,483 | +23% | +$1.39M |
|